Stage
Series B - III | AliveTotal Raised
$7.26MLast Raised
$1M | 12 yrs agoAbout Revascular Therapeutics
ReVascular Therapeutics has pioneered advances in technology for the intravascular treatment of complex lesions and total occlusions that typically cannot be treated using current catheter-based technologies and products.
Revascular Therapeutics Headquarter Location
766 Palomar Ave
Sunnyvale, California, 94085,
United States
408-617-0770
Latest Revascular Therapeutics News
Aug 22, 2013
Launched by Revascular Therapeutics Founder Brian Gormley Join Now Sign In Members Only This is the kind of news coverage and analysis you can access exclusively as a WSJ Pro Member. Copyright 2016 Dow Jones & Company, Inc. All Rights Reserved This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
Revascular Therapeutics Patents
Revascular Therapeutics has filed 12 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/10/2014 | 11/21/2017 | Automotive transmission technologies, Engine technology, Drilling technology, Electric power conversion, Mechanisms (engineering) | Grant | |
Application Date | 1/10/2014 | ||||
|---|---|---|---|---|---|
Grant Date | 11/21/2017 | ||||
Title | |||||
Related Topics | Automotive transmission technologies, Engine technology, Drilling technology, Electric power conversion, Mechanisms (engineering) | ||||
Status | Grant |